JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
What was lobbied
13 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to: - medical supply chains - TRIPS Waiver
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| DAVID KAVANAUGH | — |
| TIMOTHY SWOPE | — |
Consumer Issues/Safety/Products CSP
Issues related to: - counterfeit healthcare goods - brand protection
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Science/Technology SCI
Issues related to: - data privacy - cybersecurity - artificial intelligence
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIF BRIERLEY | — |
Budget/Appropriations BUD
Issues related to: - contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - appropriations for Labor Health and Human Services
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DEANA MCRAE | — |
| TIMOTHY SWOPE | — |
Health Issues HCR
- S 1375/HR 830, "HELP Copays Act", regarding all provisions - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions - S 1355/HR 2940, "PASTEUR Act", regarding all provisions - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions Issues related to: - obesity - biosimilars - health equity and diversity in clinical trials - myopia - ambulatory surgical services - access to sterilization capacity for medical technologies - FDA approval pathways for medical technologies - peripheral artery disease - cardiovascular health - stroke care - FDA medical device shortage reporting requirements - alternative funding programs - 340B - PBM practices - health care workforce wellbeing
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LEIF BRIERLEY | — |
| LARRY CAMM | — |
| DEANA MCRAE | — |
| AMY PELLEGRINO | — |
| ABIGAIL PINKELE | — |
| EMELY SANCHEZ | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| RILEY SWINEHART | — |
| TIMOTHY SWOPE | — |
| COLLEEN VIVALDI | — |
| KELLY WATERS | — |
Labor Issues/Antitrust/Workplace LBR
- Issues related to diversity, equity and inclusion
| Lobbyist | Covered position, as disclosed |
|---|---|
| LARRY CAMM | — |
Veterans VET
Issues related to: - Veterans Administration and Veterans Health Administration policy for return of and reuse of reprocessed medical devices; - Veterans Administration and Veterans Health Administration policy procurement and contracting processes for medical technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| RILEY SWINEHART | — |
Copyright/Patent/Trademark CPT
- S 150, "Affordable Prescriptions for Patients Act of 2023", regarding all provisions. - S 79/HR 1717, "Interagency Patent Coordination and Improvement Act of 2023", regarding all provisions - Issues related to intellectual property
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DAVID KAVANAUGH | — |
| TIMOTHY SWOPE | — |
Taxation/Internal Revenue Code TAX
S. 866/H.R. 2673, "American Innovation and R&D Competitiveness Act of 2023", regarding provisions related to research & development expensing. Issues related to: - OECD proposals on global tax & implementation - R&D expensing - corporate tax provisions in TCJA
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| DAVID KAVANAUGH | — |
| KELLY WATERS | — |
Pharmacy PHA
- HR 4490, "To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the to the ultimate user, and for other purposes", regarding all provisions - Issues related to drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY PELLEGRINO | — |
| ABIGAIL PINKELE | — |
| MEGHAN DRENAN STONE | — |
| WENDY SUSSMAN | — |
| RILEY SWINEHART | — |
| TIMOTHY SWOPE | — |
Environment/Superfund ENV
Issues related to - clean energy - environmental sustainability
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY WATERS | — |
Bankruptcy BNK
Issues related to: - Chapter 11 corporate bankruptcy process - Litigation reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANE MARGARET ADAMS | — |
| LARRY CAMM | — |
| ABIGAIL PINKELE | — |
| RILEY SWINEHART | — |
| KELLY WATERS | — |
Medicare/Medicaid MMM
Issues related to the Medicaid Drug Rebate Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY PELLEGRINO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.